Search Results

• • 13 

    Academic Journals

  • Sort by: sorttype.publication.date.desc Newest sorttype.publication.date.asc Oldest sorttype.relevance Relevance

• Select Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer--A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib

  1

  Combined Targeted Therapies for First-line Treatment of Metastatic Triple Negative Breast Cancer--A Phase II Trial of Weekly Nab-Paclitaxel and Bevacizumab Followed by Maintenance Targeted Therapy With Bevacizumab and Erlotinib

  Authors:Lynn Symonds, Hannah Linden, Vijayakrishna Gadi, Larissa Korde, Eve Rodler, Julie Gralow, et al.From:Clinical Breast Cancer (Vol. 19, Issue 2) Peer-Reviewed

  Apr. 2019462 words Author abstract, Rep...

   Abstract Only
• Select Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer.

  2

  Individualizing Extended Adjuvant Therapy in HR+ Breast Cancer.

  Authors:Vijayakrishna Gadi and Reshma L. MahtaniFrom:Oncology (Vol. 35, Issue 6) Peer-Reviewed

  June 20211,899 words Article 1630LIn the setting of hormone receptor--positive (HR+), HER2-negative, lymph node-negative (pN0) breast cancer, postsurgical antiestrogen therapy (ie, adjuvant endocrine therapy) with tamoxifen or an aromatase inhibitor is...
• Select Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer

  3

  Adjuvant continuous metronomic adriamycin + cyclophosphamide followed by weekly nab-paclitaxel for high-risk early-stage breast cancer

  Authors:Eunpi Cho, Qian Wu, Lena Rubinstein, Hannah Linden, Julie Gralow, Jennifer Specht, et al.From:Breast Journal (Vol. 24, Issue 4) Peer-Reviewed

  July-August 2018250 words Report

   Abstract Only
• Select Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base

  4

  Adjuvant Endocrine Therapy in Patients with Ductal Carcinoma In Situ: A Population-Based Retrospective Analysis from 2005 to 2012 in the National Cancer Data Base

  Authors:Meghan R. Flanagan, Mara H. Rendi, Vijayakrishna K. Gadi, Kristine E. Calhoun, Kenneth W. Gow, and Sara H. JavidFrom:Annals of Surgical Oncology (Vol. 22, Issue 10) Peer-Reviewed

  Oct. 2015365 words Report

   Abstract Only
• Select Fetal microchimerism in breast from women with and without breast cancer

  5

  Fetal microchimerism in breast from women with and without breast cancer

  Author:Vijayakrishna K. GadiFrom:Breast Cancer Research and Treatment (Vol. 121, Issue 1) Peer-Reviewed

  May 1, 20102,166 words Article 1510LA lasting legacy of a fetus to the mother is a small number of stably persistent allogeneic cells; the phenomenon known as fetal microchimerism. Prior studies demonstrated that fetal microchimerism in the peripheral...
• Select Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.

  6

  Microtransplantation in older patients with AML: A pilot study of safety, efficacy and immunologic effects.

  Authors:Anthony D. Sung, Shekeab Jauhari, Sharareh Siamakpour-Reihani, Arati V. Rao, Janet Staats, Cliburn Chan, et al.From:American Journal of Hematology (Vol. 95, Issue 6) Peer-Reviewed

  June 2020635 words Report

   Abstract Only
• Select The effect of treatment advances on the mortality results of breast cancer screening trials: a microsimulation model

  7

  The effect of treatment advances on the mortality results of breast cancer screening trials: a microsimulation model

  Authors:Jeanette Birnbaum, Vijayakrishna K. Gadi, Elan Markowitz, and Ruth EtzioniFrom:Annals of Internal Medicine (Vol. 164, Issue 4) Peer-Reviewed

  Feb. 16, 2016333 words Author abstract, Rep...

   Abstract Only
• Select Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism.

  8

  Immunogenicity of a rheumatoid arthritis protective sequence when acquired through microchimerism.

  Authors:Sami B. Kanaan, Oyku Sensoy, Zhen Yan, Vijayakrishna K. Gadi, Michael L. Richardson, and J. Lee NelsonFrom:Proceedings of the National Academy of Sciences of the United States (Vol. 116, Issue 39) Peer-Reviewed

  Sept. 24, 20198,011 words Article 1470L

   Abstract Only
• Select The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?

  9

  The use of stereotactic radiosurgery for brain metastases from breast cancer: who benefits most?

  Authors:Eunpi Cho, Lena Rubinstein, Philip Stevenson, Ted Gooley, Mark Philips, Lia M. Halasz, et al.From:Breast Cancer Research and Treatment (Vol. 149, Issue 3) Peer-Reviewed

  Feb. 1, 20154,478 words Article 1460LBrain metastases (BM) from primary breast cancer can arise despite use of systemic therapies that provide excellent extracranial disease control. Local modalities for treating BM include surgery, whole brain radiation...
• Select Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer.

  10

  Single arm, phase two study of low-dose metronomic eribulin in metastatic breast cancer.

  Authors:Pavani Chalasani, Kiah Farr, Vicky Wu, Isaac Jenkins, Alex Liu, Stephanie Parker, et al.From:Breast Cancer Research and Treatment (Vol. 188, Issue 1) Peer-Reviewed

  July 20214,516 words Article 1480L

   Citation Only
• Select Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers

  11

  Diffusion-weighted MRI characteristics associated with prognostic pathological factors and recurrence risk in invasive ER+/HER2- breast cancers

  Authors:Nita Amornsiripanitch, Vicky T. Nguyen, Habib Rahbar, Daniel S. Hippe, Vijayakrishna K. Gadi, Mara H. Rendi, et al.From:Journal of Magnetic Resonance Imaging (Vol. 48, Issue 1) Peer-Reviewed

  July 2018354 words Report

   Abstract Only
• Select Case-Control Study of Fetal Microchimerism and Breast Cancer

  12

  Case-Control Study of Fetal Microchimerism and Breast Cancer

  Authors:Vijayakrishna K. Gadi, Kathleen E. Malone, Katherine A. Guthrie, Peggy L. Porter, and J. Lee NelsonFrom:PLoS ONE (Vol. 3, Issue 3) Peer-Reviewed

  Mar. 5, 20083,344 words Article 1490LBackground Prior pregnancy is known to protect against development of breast cancer. Recent studies have demonstrated that pregnancy has the capacity to establish small numbers of immunologically active fetal-derived...
• Select Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection

  13

  Soluble donor DNA concentrations in recipient serum correlate with pancreas-kidney rejection

  Authors:Vijayakrishna K. Gadi, J. Lee Nelson, Nicholas D. Boespflug, Katherine A. Guthrie, and Christian S. KuhrFrom:Clinical Chemistry (Vol. 52, Issue 3) Peer-Reviewed

  Mar. 20062,414 words Article 1540L

   Citation Only